Clinical Trial Update: An Efficacy and Safety Study of Genolar® and Xolar® in the Persistent Atopic Bronchial Asthma [Phase 3]

View source ↗

Summary

Phase 3 trial update for Genolar® and Xolar® in persistent atopic bronchial asthma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchial Asthma

Drugs mentioned

• Genolar®
• Xolar®

Snippet

Sponsor: AO GENERIUM | Conditions: Bronchial Asthma | Phase 3 | Status: COMPLETED